Novolog Pharm-Up 1966 Ltd (NVLG) — Capital Reinvestment Ratio
Latest as of September 2025:
1.41x
Novolog Pharm-Up 1966 Ltd (NVLG) has a Capital Reinvestment Ratio of 1.41x as of September 2025, meaning it reinvests 1% of its operating cash flow (ILA15.42 Million) in capital expenditures (ILA21.78 Million). See NVLG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.41x
Capex / Operating Cash Flow
Operating Cash Flow
ILA15.42 Million
ILA
Capital Expenditures
ILA21.78 Million
ILA
Data as of
Sep 2025
Most recent filing
Novolog Pharm-Up 1966 Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Novolog Pharm-Up 1966 Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Novolog Pharm-Up 1966 Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Novolog Pharm-Up 1966 Ltd from 2014 to 2024. For live market cap and broader valuation context, see how much is Novolog Pharm-Up 1966 Ltd worth.
| Year | Reinvestment Ratio | Operating CF (ILA) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.37x | ILA158.52 Million | ILA58.74 Million | ▲ +4.4% |
| 2023 | 0.35x | ILA200.01 Million | ILA70.95 Million | ▼ -32.3% |
| 2022 | 0.52x | ILA132.65 Million | ILA69.49 Million | ▲ +42.6% |
| 2021 | 0.37x | ILA83.39 Million | ILA30.64 Million | ▼ -16.1% |
| 2020 | 0.44x | ILA58.48 Million | ILA25.61 Million | ▲ +77.6% |
| 2019 | 0.25x | ILA101.45 Million | ILA25.01 Million | ▼ -79.8% |
| 2018 | 1.22x | ILA23.96 Million | ILA29.27 Million | ▲ +202.4% |
| 2017 | 0.40x | ILA86.37 Million | ILA34.89 Million | ▼ -38.5% |
| 2016 | 0.66x | ILA20.28 Million | ILA13.32 Million | ▲ +700.7% |
| 2015 | 0.08x | ILA140.29 Million | ILA11.50 Million | ▲ +381.8% |
| 2014 | 0.02x | ILA160.59 Million | ILA2.73 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow